Weize Li
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Traditional Chinese Medicine Analysis
Papers in ⓘ
-
- Circular RNAs in diseases 2
-
- Advanced Drug Delivery Systems 5
- Advancements in Transdermal Drug Delivery 4
- Co-authors
- Hao Bao-hua (3 shared papers)Ning Zhao (6 shared papers)Lei Xu (1 shared paper)Lvyi Chen (1 shared paper)Yongqiang Zhou (3 shared papers)Yongqiang Zhou (1 shared paper)Yong Zhang (1 shared paper)Meirong Huo (1 shared paper)
In The Last Decade
Weize Li
27 papers receiving 673 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 288
- Complementary and alternative medicine 119
- Dermatology 91
- Pharmacology 56
- Pharmacology 89
Countries citing papers authored by Weize Li
This map shows the geographic impact of Weize Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Li more than expected).
Fields of papers citing papers by Weize Li
This network shows the impact of papers produced by Weize Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Li. The network helps show where Weize Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Weize Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 160 | |
| 2 | 2012 | 107 | |
| 3 | 2011 | 99 | |
| 4 | 2010 | 64 | |
| 5 | 2009 | 53 | |
| 6 | 2012 | 39 | |
| 7 | 2016 | 38 | |
| 8 | 2016 | 37 | |
| 9 | 2020 | 17 | |
| 10 | 2024 | 14 | |
| 11 | 2023 | 10 | |
| 12 | 2020 | 8 | |
| 13 | 2021 | 6 | |
| 14 | 2017 | 5 | |
| 15 | 2023 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2023 | 3 | |
| 19 | LncRNA-Anrel promotes the proliferation and migration of synovial fibroblasts through regulating miR-146a-mediated annexin A1 expression. | 2023 | 3 |
| 20 | The optimization of total flavonoids from rhizoma drynariae by response surface methodology and the metal ion chelation activity assay. | 2021 | 3 |
About Weize Li
Weize Li is a scholar working on Molecular Biology, Pharmaceutical Science, Immunology, Organic Chemistry and Pharmacology, having authored 28 papers that have together received 687 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Advancements in Transdermal Drug Delivery (4 papers), Phytochemistry and Biological Activities (3 papers), Alzheimer's disease research and treatments (2 papers), Circular RNAs in diseases (2 papers), Traditional Chinese Medicine Analysis (2 papers), Hydrogels: synthesis, properties, applications (2 papers) and Catalytic Cross-Coupling Reactions (2 papers). The work is most often cited by research in Pharmaceutical Science (288 citations), Complementary and alternative medicine (119 citations), Dermatology (91 citations), Pharmacology (56 citations) and Pharmacology (89 citations). Weize Li has collaborated with scholars based in China, Australia and Croatia. Frequent co-authors include Hao Bao-hua, Ning Zhao, Lei Xu, Lvyi Chen, Yongqiang Zhou, Yongqiang Zhou, Yong Zhang, Meirong Huo, Ting Liu and Jianping Zhou. Their work appears in journals such as Environmental Toxicology and Pharmacology, European Journal of Pharmaceutical Sciences, Organic & Biomolecular Chemistry, Biomarker Research and Journal of Enzyme Inhibition and Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.